Sunday, March 1, 2020

European Summit on Pharmacology and Toxicology


DR. RUSSELL BIALECKI (OCM )
Janssen Pharmaceutical Companies of Johnson Johnson
I am a highly accomplished, published, top-performing Scientist/Director with 20+ years of high-impact, non-clinical research and development experience spanning the pharmaceutical and chemical industries. I bring proven Expertise in pharmacology, toxicology, non-clinical and commercial drug development. My record includes cultivating strong team building and leadership, organizational development, Good Laboratory Practices (GLP), non-GLP and delivering significant results. Recognized with earned accolades as an energetic, intuitive and articulate communicator, continually focused on building and strengthening relationships across all organizational levels to drive consensus for unified strategies that further enterprise goals. Successes Include: • Designing, implementing and interpreting nonclinical safety studies to support project progression. • Problem-solving to clarify underpinning mechanisms of action and mitigating potential issues. • Placing results in the context of relevant regulatory guidelines and the human condition. • Analyzing operation budgets, P&L and forecasting book of work. • Mentoring team and cross-functional teammates to increase delivery. • Managing time to strategically organize and lead projects over $7MM. • Facilitating company integration to increase operational efficiency by 40% during a merger. • Providing support and communications to ensure delivery of studies on time, on budget and to quality. Expertise Includes: Director of Toxicology & Pharmacology | Pharmaceuticals & Biotechnology.
For more details regarding the international conference "Pharmacology Congress 2020"Kindly contact :Bommali SConference Scientific Event Manager| Pharmacology Congress 2020 |
Longdom Conferences | LONGDOM GROUP SA
Avenue Roger Vandendriessche, 18, 1150 Brussels, Belgium
Toll Free: +3253280122 | Whatsapp: +32466903214
Email: pharmacologycongress@longdommeetings.com


No comments:

Post a Comment